BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14723702)

  • 1. Determination of Cryptosporidium parvum oocyst viability by fluorescence in situ hybridization using a ribosomal RNA-directed probe.
    Smith JJ; Gunasekera TS; Barardi CR; Veal D; Vesey G
    J Appl Microbiol; 2004; 96(2):409-17. PubMed ID: 14723702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of a ribosomal RNA targeted oligonucleotide probe for fluorescent labelling of viable Cryptosporidium parvum oocysts.
    Vesey G; Ashbolt N; Fricker EJ; Deere D; Williams KL; Veal DA; Dorsch M
    J Appl Microbiol; 1998 Sep; 85(3):429-40. PubMed ID: 9750273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid method for fluorescent in situ ribosomal RNA labelling of Cryptosporidium parvum.
    Deere D; Vesey G; Milner M; Williams K; Ashbolt N; Veal D
    J Appl Microbiol; 1998 Nov; 85(5):807-18. PubMed ID: 9830116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of 18S rRNA and rDNA stability by real-time RT-PCR in heat-inactivated Cryptosporidium parvum oocysts.
    Fontaine M; Guillot E
    FEMS Microbiol Lett; 2003 Sep; 226(2):237-43. PubMed ID: 14553917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time nucleic acid sequence-based amplification (NASBA) assay targeting MIC1 for detection of Cryptosporidium parvum and Cryptosporidium hominis oocysts.
    Hønsvall BK; Robertson LJ
    Exp Parasitol; 2017 Jan; 172():61-67. PubMed ID: 27998735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct counting of Cryptosporidium parvum oocysts using fluorescence in situ hybridization on a membrane filter.
    Taguchi T; Shinozaki Y; Takeyama H; Haraguchi S; Yoshino M; Kaneko M; Ishimori Y; Matsunaga T
    J Microbiol Methods; 2006 Nov; 67(2):373-80. PubMed ID: 16793153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and determination of the viability of Giardia lamblia cysts and Cryptosporidium parvum and Cryptosporidium hominis oocysts in human fecal and water supply samples by fluorescent in situ hybridization (FISH) and monoclonal antibodies.
    Lemos V; Graczyk TK; Alves M; Lobo ML; Sousa MC; Antunes F; Matos O
    Parasitol Res; 2005 Dec; 98(1):48-53. PubMed ID: 16261356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival of Cryptosporidium parvum oocysts in the presence of hydrated lime.
    Zintl A; Keogh B; Ezzaty-Mirhashemi M; De Waal T; Scholz D; Mulcahy G
    Vet Rec; 2010 Mar; 166(10):297-300. PubMed ID: 20208077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of tests for viable and infectious Cryptosporidium parvum oocysts.
    Jenkins M; Trout JM; Higgins J; Dorsch M; Veal D; Fayer R
    Parasitol Res; 2003 Jan; 89(1):1-5. PubMed ID: 12474036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the viability of Cryptosporidium parvum oocysts with the induction ratio of hsp70 mRNA production in manure.
    Garcés-Sanchez G; Wilderer PA; Horn H; Munch JC; Lebuhn M
    J Microbiol Methods; 2013 Sep; 94(3):280-9. PubMed ID: 23747597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Die-off of Cryptosporidium parvum in soil and wastewater effluents.
    Nasser AM; Tweto E; Nitzan Y
    J Appl Microbiol; 2007 Jan; 102(1):169-76. PubMed ID: 17184332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of viable Cryptosporidium parvum in soil by reverse transcription-real-time PCR targeting hsp70 mRNA.
    Liang Z; Keeley A
    Appl Environ Microbiol; 2011 Sep; 77(18):6476-85. PubMed ID: 21803904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vitro viability methods for Cryptosporidium oocysts.
    Vande Burgt NH; Auer A; Zintl A
    Exp Parasitol; 2018 Apr; 187():30-36. PubMed ID: 29518450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of relative proportions of intact cells in microbiological samples using the example of Cryptosporidium parvum oocysts.
    Agulló-Barceló M; Moss JA; Green J; Gillespie S; Codony F; Lucena F; Nocker A
    Lett Appl Microbiol; 2014 Jan; 58(1):70-8. PubMed ID: 24024645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CP2 gene as a useful viability marker for Cryptosporidium parvum.
    Lee SU; Joung M; Ahn MH; Huh S; Song H; Park WY; Yu JR
    Parasitol Res; 2008 Feb; 102(3):381-7. PubMed ID: 18060431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of time and temperature on flow cytometry enumerated live Cryptosporidium parvum oocysts.
    Ware MW; Schaefer FW
    Lett Appl Microbiol; 2005; 41(5):385-9. PubMed ID: 16238640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptosporidium parvum oocyst viability and behaviour of the residual body during the excystation process.
    Kar S; Daugschies A; Cakmak A; Yilmazer N; Dittmar K; Bangoura B
    Parasitol Res; 2011 Dec; 109(6):1719-23. PubMed ID: 21603913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptosporidium parvum studies with dairy products.
    Deng MQ; Cliver DO
    Int J Food Microbiol; 1999 Feb; 46(2):113-21. PubMed ID: 10728612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viability and infectivity of Cryptosporidium parvum oocysts detected in river water in Hokkaido, Japan.
    Tsushima Y; Karanis P; Kamada T; Xuan X; Makala LH; Tohya Y; Akashi H; Nagasawa H
    J Vet Med Sci; 2003 May; 65(5):585-9. PubMed ID: 12808210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative assessment of viable Cryptosporidium parvum load in commercial oysters (Crassostrea virginica) in the Chesapeake Bay.
    Graczyk TK; Lewis EJ; Glass G; Dasilva AJ; Tamang L; Girouard AS; Curriero FC
    Parasitol Res; 2007 Jan; 100(2):247-53. PubMed ID: 16896650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.